ArticleWorld journal of clinical oncology2024

Ferroptosis biomarkers predict tumor mutation burden's impact on prognosis in HER2-positive breast cancer.

Jin-Yu Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.